BIT 2.63% 3.7¢ biotron limited

Ann: BIT225 Phase 2 HIV Efficacy Trial Meets Primary Objectives, page-65

  1. 135 Posts.
    lightbulb Created with Sketch. 17
    that’s correct. The last release was prelim for trial 10 and this one’s for trial 11. These were the ones that they said they would release this quarter but don’t think it will change investor sentiment much because it doesn’t say anything new. But I suppose they’ve ‘kind of’ done what they said they were going to do?

    no final results as yet….they require ‘detailed analysis’ so who knows how long that will take!!

    see what this quarterly brings….
 
watchlist Created with Sketch. Add BIT (ASX) to my watchlist
(20min delay)
Last
3.7¢
Change
-0.001(2.63%)
Mkt cap ! $33.38M
Open High Low Value Volume
3.9¢ 4.0¢ 3.7¢ $38.58K 1.029M

Buyers (Bids)

No. Vol. Price($)
2 511933 3.7¢
 

Sellers (Offers)

Price($) Vol. No.
4.0¢ 93887 2
View Market Depth
Last trade - 14.30pm 03/07/2024 (20 minute delay) ?
BIT (ASX) Chart
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.